Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort

Abstract Background Safety and efficacy of immune checkpoint inhibitors in advanced gastric or gastroesophageal junction (GEJ) cancer could be demonstrated in predominantly Asian cohorts, whereas data in Western patients outside of clinical trials are vastly missing. Methods In this multi-institutio...

詳細記述

書誌詳細

出版年:	BMC Cancer
主要な著者:	Verena Schlintl, Florian Huemer, Gabriel Rinnerthaler, Thomas Melchardt, Thomas Winder, Patrick Reimann, Jakob Riedl, Arno Amann, Wolfgang Eisterer, Franz Romeder, Gudrun Piringer, Aysegül Ilhan-Mutlu, Ewald Wöll, Richard Greil, Lukas Weiss
フォーマット:	論文
言語:	英語
出版事項:	BMC 2022-01-01
主題:	Gastric cancer Nivolumab Pembrolizumab Immunotherapy
オンライン･アクセス:	https://doi.org/10.1186/s12885-021-09115-6